1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics in North America Countries, June 2016 (p7)

Biopharmaceutical Analysis & Statistics in North America Countries, June 2016 (p7)

181-210 of about 300 reports

Purchase Reports From Reputable Market Research Publishers

Array BioPharma, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : United States

Abeona Therapeutics, Inc. (formerly PlasmaTech Biopharmaceuticals, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2016
  • by MarketLine

Summary Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an ...

  • Industries : Pharmaceutical, Therapy
  • Countries : United States

Breast Cancer - Pipeline Review, H1 2016

  • $ 2500
  • Company report
  • June 2016
  • by Global Markets Direct

Breast Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Breast Cancer pipeline landscape. The report provides ...

  • Industries : Pathology, Cancer
  • Countries : United States, North America

T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Pipeline Review, H1 2016

  • $ 3500
  • Company report
  • June 2016
  • by Global Markets Direct

T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘T-Cell Surface Glycoprotein CD3 Epsilon ...

  • Industries : Therapy, Oncology, Pathology
  • Countries : United States, World

Insulin Like Growth Factor 1 (Mechano Growth Factor or Somatomedin-C or IGF-1) - Pipeline Review, H1 2016

  • $ 3500
  • Company report
  • June 2016
  • by Global Markets Direct

Insulin Like Growth Factor 1 (Mechano Growth Factor or Somatomedin-C or IGF-1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Insulin Like Growth Factor 1 (Mechano Growth Factor or Somatomedin-C ...

  • Industries : Biopharmaceutical, Therapy
  • Countries : World, United States

Insulin Like Growth Factor 2 (Somatomedin-A or IGF-2) - Pipeline Review, H1 2016

  • $ 3500
  • Company report
  • June 2016
  • by Global Markets Direct

Insulin Like Growth Factor 2 (Somatomedin-A or IGF-2) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Insulin Like Growth Factor 2 (Somatomedin-A or IGF-2) - Pipeline Review, H1 2016’, ...

  • Industries : Biopharmaceutical, Therapy
  • Countries : World, United States

Liver Cancer - Pipeline Review, H1 2016

  • $ 2500
  • Company report
  • June 2016
  • by Global Markets Direct

Liver Cancer - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2016’, provides an overview of the Liver Cancer pipeline landscape. The report provides ...

  • Industries : Pathology, Cancer
  • Countries : United States, North America

Wegener Polyangiitis - Pipeline Review, H1 2016

  • $ 2000
  • Company report
  • June 2016
  • by Global Markets Direct

Wegener Polyangiitis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Wegener Polyangiitis - Pipeline Review, H1 2016’, provides an overview of the Wegener Polyangiitis pipeline landscape. ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States

Glycoprotein 41 (gp41) - Pipeline Review, H1 2016

  • $ 3500
  • Company report
  • June 2016
  • by Global Markets Direct

Glycoprotein 41 (gp41) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Glycoprotein 41 (gp41) - Pipeline Review, H1 2016’, provides in depth analysis on Glycoprotein 41 (gp41) targeted ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : France, United States, World

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2016

  • $ 3500
  • Company report
  • June 2016
  • by Global Markets Direct

Tumor Necrosis Factor Receptor Superfamily Member 4 (ACT35 Antigen or TAX Transcriptionally Activated Glycoprotein 1 Receptor or CD134 or TNFRSF4) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Oncology
  • Countries : United States, World

Cytotoxic T-Lymphocyte Protein 4 (CTLA-4 or CD152) - Pipeline Review, H1 2016

  • $ 3500
  • Company report
  • June 2016
  • by Global Markets Direct

Cytotoxic T-Lymphocyte Protein 4 (CTLA-4 or CD152) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Cytotoxic T-Lymphocyte Protein 4 (CTLA-4 or CD152) - Pipeline Review, H1 2016’, provides ...

  • Industries : Therapy, Biological Therapy, Oncology, Biotechnology, Pharmaceutical
  • Countries : United States, World

Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016

  • $ 2000
  • Company report
  • June 2016
  • by Global Markets Direct

Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) - Pipeline Review, ...

  • Industries : Therapy, Pathology, Chronic Disease, Pharmaceutical, Healthcare
  • Countries : United States

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016

  • $ 2000
  • Company report
  • June 2016
  • by Global Markets Direct

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, ...

  • Industries : Pathology, Therapy, Research and Development, Healthcare, Pharmaceutical
  • Countries : United States

Nanosphere, Inc. (NSPH) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • June 2016
  • by GlobalData

Summary Nanosphere, Inc. (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products ...

  • Industries : Biotechnology, In Vitro Diagnostics, Pathology, Cancer, Healthcare
  • Countries : United States

Alliqua BioMedical, Inc. (ALQA) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • June 2016
  • by GlobalData

Summary Alliqua BioMedical, Inc. (Alliqua BioMedical) formerly HepaLife Technologies Inc. is a medical device company that offers wound care solutions. The company offers wound care, transdermal drug delivery, ...

  • Industries : Biopharmaceutical
  • Countries : United States

Sekisui Medical Co., Ltd. - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • June 2016
  • by GlobalData

Summary Sekisui Medical Co., Ltd. (Sekisui Medical), a subsidiary of Sekisui Diagnostics, LLC. is a medical company that develops, produces, and distributes diagnostic reagents, medical devices, pharmaceuticals, ...

  • Industries : Biopharmaceutical, In Vitro Diagnostics
  • Countries : United States, Japan, World

Glucosylceramidase (Acid Beta-Glucosidase or Alglucerase or D-Glucosyl-N-Acylsphingosine Glucohydrolase or EC 3.2.1.45) - Pipeline Review, H1 2016

  • $ 3500
  • Company report
  • May 2016
  • by Global Markets Direct

Glucosylceramidase (Acid Beta-Glucosidase or Alglucerase or D-Glucosyl-N-Acylsphingosine Glucohydrolase or EC 3.2.1.45) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Glucosylceramidase ...

  • Industries : Biopharmaceutical, Biotechnology, Pathology, Therapy, Pharmaceutical
  • Countries : World, United States, Japan

Alpha-Galactosidase A (Alpha-D-Galactosidase A or Alpha-D-Galactoside Galactohydrolase or Melibiase or EC 3.2.1.22) - Pipeline Review, H1 2016

  • $ 3500
  • Company report
  • May 2016
  • by Global Markets Direct

Alpha-Galactosidase A (Alpha-D-Galactosidase A or Alpha-D-Galactoside Galactohydrolase or Melibiase or EC 3.2.1.22) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Alpha-Galactosidase ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : United States, World

Growth Hormone Secretagogue Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or Ghrelin Receptor or GHSR) - Pipeline Review, H1 2016

  • $ 3500
  • Company report
  • April 2016
  • by Global Markets Direct

Growth Hormone Secretagogue Receptor Type 1 (GHS-R or GH-Releasing Peptide Receptor or GHRP or Ghrelin Receptor or GHSR) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Growth Hormone ...

  • Industries : Pharmaceutical, Therapy, Biopharmaceutical, Pathology
  • Countries : World, United States

Febrile Neutropenia - Pipeline Review, H1 2016

  • $ 2000
  • Company report
  • April 2016
  • by Global Markets Direct

Febrile Neutropenia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Febrile Neutropenia - Pipeline Review, H1 2016’, provides an overview of the Febrile Neutropenia pipeline landscape. ...

  • Industries : Therapy, Research and Development, Biological Therapy
  • Countries : United States, World

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016

  • $ 2000
  • Company report
  • April 2016
  • by Global Markets Direct

Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016’, provides an overview of the Plaque ...

  • Industries : Pathology, Healthcare
  • Countries : United States

Anemia in chronic kidney disease

  • $ 5000
  • Industry report
  • April 2016
  • by Datamonitor Healthcare

The launch of novel HIF inhibitor roxadustat will offset biosimilar erosion of Epogen to drive market growth. This report addresses the following questions: - What does the future look like for the e ...

  • Industries : Pathology, Healthcare, Chronic Disease
  • Countries : Japan, Europe, Asia, World, United States

SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • March 2016
  • by Global Markets Direct

SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2016’, provides an overview of the SK ...

  • Industries : Biopharmaceutical, Research and Development, Therapy, Mental Health, Biotechnology, Pathology, Pharmaceutical
  • Countries : United States

Saladax Biomedical, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States

Cytovance Biologics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States

KBI BioPharma, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
  • Countries : United States, United Kingdom

Synageva BioPharma Corp. (formerly AviGenics, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
  • Countries : United States

Oncolys Biopharma, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United States

Compass Biotechnologies, Inc. (formerly Cyplasin Biomedical, Ltd.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United States, United Kingdom, Canada

Aldagen, Inc. (formerly Stemco Biomedical, Inc.) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.